FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 298:1384-1386 June 22, 1978 Number 25 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To determine whether tumors containing carcinoembryonic antigen could be detected by administration of a radiolabeled, affinity-purified, goat lgG having 70 per cent immunoreactivity against carcinoembryonic antigen, 18 patients with a history of cancer of diverse histopathology received an average total dose of 1.0 mCi of 131l-labeled lgG. Total-body photoscans were performed with a gamma scintillation camera at various intervals after administration of the radioactive antibody. Ordinary photoscans proved difficult to interpret because of blood-pool background radioactivity, thus necessitating the computer subtraction of radioactive blood-pool agents from the antibody's 131l activity. Tumor location could be demonstrated at 48 hours after injection in almost all cases studied. The scans were negative in patients without demonstrable tumors or with tumors apparently devoid of carcinoembryonic antigen. Circulating antigen levels of up to 350 ng per milliliter did not prevent successful tumor imaging after injection of the radioantibody.

This article has been cited by other articles:

• Parkhurst, M. R., Joo, J., Riley, J. P., Yu, Z., Li, Y., Robbins, P. F., Rosenberg, S. A. (2009). Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691-699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer Cells. Clin. Cancer Res. 15: 169-180 [Abstract] [Full Text]  
• Liersch, T., Meller, J., Bittrich, M., Kulle, B., Becker, H., Goldenberg, D. M. (2007). Update of Carcinoembryonic Antigen Radioimmunotherapy with 131I-Labetuzumab After Salvage Resection of Colorectal Liver Metastases: Comparison of Outcome to a Contemporaneous Control Group. Ann. Surg. Oncol. 14: 2577-2590 [Abstract] [Full Text]  
• Sharkey, R. M., Goldenberg, D. M. (2006). Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates. CA Cancer J Clin 56: 226-243 [Abstract] [Full Text]  
• Kelloff, G. J., Krohn, K. A., Larson, S. M., Weissleder, R., Mankoff, D. A., Hoffman, J. M., Link, J. M., Guyton, K. Z., Eckelman, W. C., Scher, H. I., O'Shaughnessy, J., Cheson, B. D., Sigman, C. C., Tatum, J. L., Mills, G. Q., Sullivan, D. C., Woodcock, J. (2005). The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development. Clin. Cancer Res. 11: 7967-7985 [Abstract] [Full Text]  
• Sharkey, R. M., Karacay, H., Cardillo, T. M., Chang, C.-H., McBride, W. J., Rossi, E. A., Horak, I. D., Goldenberg, D. M. (2005). Improving the Delivery of Radionuclides for Imaging and Therapy of Cancer Using Pretargeting Methods. Clin. Cancer Res. 11: 7109s-7121s [Abstract] [Full Text]  
• Stein, R., Govindan, S. V., Hayes, M., Griffiths, G. L., Hansen, H. J., Horak, I. D., Goldenberg, D. M. (2005). Advantage of a Residualizing Iodine Radiolabel in the Therapy of a Colon Cancer Xenograft Targeted with an Anticarcinoembryonic Antigen Monoclonal Antibody. Clin. Cancer Res. 11: 2727-2734 [Abstract] [Full Text]  
• Sharkey, R. M., Goldenberg, D. M. (2005). Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies. JNM 46: 115S-127S [Abstract] [Full Text]  
• Jhanwar, Y. S., Divgi, C. (2005). Current Status of Therapy of Solid Tumors. JNM 46: 141S-150S [Abstract] [Full Text]  
• Wong, J. Y. C., Chu, D. Z., Williams, L. E., Yamauchi, D. M., Ikle, D. N., Kwok, C. S., Liu, A., Wilczynski, S., Colcher, D., Yazaki, P. J., Shively, J. E., Wu, A. M., Raubitschek, A. A. (2004). Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer. Clin. Cancer Res. 10: 5014-5021 [Abstract] [Full Text]  
• van Schaijk, F. G., Oosterwijk, E., Soede, A. C., Oyen, W. J. G., McBride, W. J., Griffiths, G. L., Goldenberg, D. M., Corstens, F. H. M., Boerman, O. C. (2003). Pretargeting with Labeled Bivalent Peptides Allowing the Use of Four Radionuclides: 111In, 131I, 99mTc, and 188Re. Clin. Cancer Res. 9: 3880S-3885 [Abstract] [Full Text]  
• Rossi, E. A., Sharkey, R. M., McBride, W., Karacay, H., Zeng, L., Hansen, H. J., Goldenberg, D. M., Chang, C.-H. (2003). Development of New Multivalent-bispecific Agents for Pretargeting Tumor Localization and Therapy. Clin. Cancer Res. 9: 3886S-3896 [Abstract] [Full Text]  
• Sharkey, R. M., Karacay, H., Richel, H., McBride, W. J., Rossi, E. A., Chang, K., Yeldell, D., Griffiths, G. L., Hansen, H. J., Goldenberg, D. M. (2003). Optimizing Bispecific Antibody Pretargeting for Use in Radioimmunotherapy. Clin. Cancer Res. 9: 3897S-3913 [Abstract] [Full Text]  
• Reubi, J. C. (2003). Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy. Endocr. Rev. 24: 389-427 [Abstract] [Full Text]  
• De Pascalis, R., Iwahashi, M., Tamura, M., Padlan, E. A., Gonzales, N. R., Santos, A. D., Giuliano, M., Schuck, P., Schlom, J., Kashmiri, S. V. S. (2002). Grafting of "Abbreviated" Complementarity-Determining Regions Containing Specificity-Determining Residues Essential for Ligand Contact to Engineer a Less Immunogenic Humanized Monoclonal Antibody. J. Immunol. 169: 3076-3084 [Abstract] [Full Text]  
• Goldenberg, D. M. (2002). Targeted Therapy of Cancer with Radiolabeled Antibodies. JNM 43: 693-713 [Abstract] [Full Text]  
• Liu, G., Mang'era, K., Liu, N., Gupta, S., Rusckowski, M., Hnatowich, D. J. (2002). Tumor Pretargeting in Mice Using 99mTc-Labeled Morpholino, a DNA Analog. JNM 43: 384-391 [Abstract] [Full Text]  
• Gutowski, M., Carcenac, M., Pourquier, D., Larroque, C., Saint-Aubert, B., Rouanet, P., Pèlegrin, A. (2001). Intraoperative Immunophotodetection for Radical Resection of Cancers: Evaluation in an Experimental Model. Clin. Cancer Res. 7: 1142-1148 [Abstract] [Full Text]  
• Behr, T. M., Blumenthal, R. D., Memtsoudis, S., Sharkey, R. M., Gratz, S., Becker, W., Goldenberg, D. M. (2000). Cure of Metastatic Human Colonic Cancer in Mice with Radiolabeled Monoclonal Antibody Fragments. Clin. Cancer Res. 6: 4900-4907 [Abstract] [Full Text]  
• Willkomm, P., Bender, H., Bangard, M., Decker, P., Grunwald, F., Biersack, H.-J. (2000). FDG PET and Immunoscintigraphy with 99mTc-Labeled Antibody Fragments for Detection of the Recurrence of Colorectal Carcinoma. JNM 41: 1657-1663 [Abstract] [Full Text]  
• Cohen, A. M., Martin, E. W. Jr, Lavery, I., Daly, J., Sardi, A., Aitken, D., Bland, K., Mojzisik, C., Hinkle, G. (1991). Radioimmunoguided Surgery Using Iodine 125 B72.3 in Patients With Colorectal Cancer. Arch Surg 126: 349-352 [Abstract]  
• Doerr, R. J., Abdel-Nabi, H., Baker, J. M., Steinberg, S. (1990). Detection of Primary Colorectal Cancer With Indium 111 Monoclonal Antibody B72.3. Arch Surg 125: 1601-1605 [Abstract]  
• Doerr, R. J., Abdel-Nabi, H., Merchant, B. (1990). Indium 111 ZCE-025 Immunoscintigraphy in Occult Recurrent Colorectal Cancer With Elevated Carcinoembryonic Antigen Level. Arch Surg 125: 226-229 [Abstract]  
• Hinkle, G. H., Beightol, R. W., Gregorio, N., Lefevre, S. R. (1989). Pharmacy Considerations Related to Radiolabeled Monoclonal Antibodies. Journal of Pharmacy Practice 2: 177-184 [Abstract]  
• O'Dwyer, P. J., Mojzisik, C. M., Hinkle, G. H., Rousseau, M., Olsen, J., Tuttle, S. E., Barth, R. F., Thurston, M. O., McCabe, D. P., Farrar, W. B., Martin, E. W. Jr (1986). Intraoperative Probe-Directed Immunodetection Using a Monoclonal Antibody. Arch Surg 121: 1391-1394 [Abstract]  
• Duda, R. B., Beatty, J. D., Sheibani, K., Williams, L. E., Paxton, R. J., Beatty, B. G., Shively, J. E., Vlahos, W. G., Werner, J. L., Kemeny, M. M., Kokal, W. A., Riihimaki, D. U., Wagman, L. D., Terz, J. J. (1986). Imaging of Human Colorectal Adenocarcinoma With Indium-Labeled Anticarcinoembryonic Antigen Monoclonal Antibody. Arch Surg 121: 1315-1319 [Abstract]  
• Patt, Y. Z., Mavligit, G., Chuang, V. P., Faltely, J. (1980). Arteriovenous Carcinoembryonic Antigen Gradient: Determination by Selective Angiography for Localization of Metastatic Colorectal Cancer. Arch Surg 115: 1122-1124 [Abstract]  
• Goldenberg, D., Kim, E., DeLand, F., van, N. J. Jr, Javadpour, N (1980). Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotropin. Science 208: 1284-1286 [Abstract]  
• Ballou, B, Levine, G, Hakala, T., Solter, D (1979). Tumor location detected with radioactively labeled monoclonal antibody and external scintigraphy. Science 206: 844-847 [Abstract]  
• Stimmel, J. B., Merrill, B. M., Kuyper, L. F., Moxham, C. P., Hutchins, J. T., Fling, M. E., Kull, F. C. Jr. (2000). Site-specific Conjugation on Serine right-arrow Cysteine Variant Monoclonal Antibodies. J. Biol. Chem. 275: 30445-30450 [Abstract] [Full Text]  
• Wu, A. M., Yazaki, P. J., Tsai, S.-w., Nguyen, K., Anderson, A.-L., McCarthy, D. W., Welch, M. J., Shively, J. E., Williams, L. E., Raubitschek, A. A., Wong, J. Y. C., Toyokuni, T., Phelps, M. E., Gambhir, S. S. (2000). High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc. Natl. Acad. Sci. USA 97: 8495-8500 [Abstract] [Full Text]